4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one

C124H167N25O10 — CID 161133803

IUPAC4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one
SMILESCCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCCC3)c1)CCC(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CNCC3CC3)c1)CCC(=O)C2.Nc1nc(OC2CCCC2)nc2c1CC(=O)CCN2Cc1cccc(CN2CCCC2)c1.Nc1nc(OCC2CCC2)nc2c1CC(=O)CCN2Cc1cccc(CN2CCCC2)c1.Nc1nc(OCCC2CC2)nc2c1CC(=O)CCN2Cc1cccc(CN2CCCC2)c1
InChIInChI=1S/3C25H33N5O2.C25H35N5O2.C24H33N5O2/c26-23-22-14-21(31)9-12-30(24(22)28-25(27-23)32-17-18-5-3-6-18)16-20-8-4-7-19(13-20)15-29-10-1-2-11-29;26-23-22-15-20(31)10-13-30(24(22)28-25(27-23)32-21-8-1-2-9-21)17-19-7-5-6-18(14-19)16-29-11-3-4-12-29;26-23-22-15-21(31)8-12-30(24(22)28-25(27-23)32-13-9-18-6-7-18)17-20-5-3-4-19(14-20)16-29-10-1-2-11-29;1-2-3-14-32-25-27-23(26)22-16-21(31)10-13-30(24(22)28-25)18-20-9-7-8-19(15-20)17-29-11-5-4-6-12-29;1-2-3-11-31-24-27-22(25)21-13-20(30)9-10-29(23(21)28-24)16-19-6-4-5-18(12-19)15-26-14-17-7-8-17/h4,7-8,13,18H,1-3,5-6,9-12,14-17H2,(H2,26,27,28);5-7,14,21H,1-4,8-13,15-17H2,(H2,26,27,28);3-5,14,18H,1-2,6-13,15-17H2,(H2,26,27,28);7-9,15H,2-6,10-14,16-18H2,1H3,(H2,26,27,28);4-6,12,17,26H,2-3,7-11,13-16H2,1H3,(H2,25,27,28)
InChIKeyUMNMUCMXDPFGTM-UHFFFAOYSA-N
MW2167.86 g/mol
LogP17.21
Rot. Bonds39

About 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one

4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one (PubChem CID 161133803) has the molecular formula C124H167N25O10 and a molecular weight of 2167.86 g/mol. Its IUPAC name is 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one.

Molecular Properties

Compound Name4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one
PubChem CID161133803
Molecular FormulaC124H167N25O10
Molecular Weight2167.86 g/mol
Exact Mass2166.33
IUPAC Name4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one
SMILESCCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCCC3)c1)CCC(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CNCC3CC3)c1)CCC(=O)C2.Nc1nc(OC2CCCC2)nc2c1CC(=O)CCN2Cc1cccc(CN2CCCC2)c1.Nc1nc(OCC2CCC2)nc2c1CC(=O)CCN2Cc1cccc(CN2CCCC2)c1.Nc1nc(OCCC2CC2)nc2c1CC(=O)CCN2Cc1cccc(CN2CCCC2)c1
InChIInChI=1S/3C25H33N5O2.C25H35N5O2.C24H33N5O2/c26-23-22-14-21(31)9-12-30(24(22)28-25(27-23)32-17-18-5-3-6-18)16-20-8-4-7-19(13-20)15-29-10-1-2-11-29;26-23-22-15-20(31)10-13-30(24(22)28-25(27-23)32-21-8-1-2-9-21)17-19-7-5-6-18(14-19)16-29-11-3-4-12-29;26-23-22-15-21(31)8-12-30(24(22)28-25(27-23)32-13-9-18-6-7-18)17-20-5-3-4-19(14-20)16-29-10-1-2-11-29;1-2-3-14-32-25-27-23(26)22-16-21(31)10-13-30(24(22)28-25)18-20-9-7-8-19(15-20)17-29-11-5-4-6-12-29;1-2-3-11-31-24-27-22(25)21-13-20(30)9-10-29(23(21)28-24)16-19-6-4-5-18(12-19)15-26-14-17-7-8-17/h4,7-8,13,18H,1-3,5-6,9-12,14-17H2,(H2,26,27,28);5-7,14,21H,1-4,8-13,15-17H2,(H2,26,27,28);3-5,14,18H,1-2,6-13,15-17H2,(H2,26,27,28);7-9,15H,2-6,10-14,16-18H2,1H3,(H2,26,27,28);4-6,12,17,26H,2-3,7-11,13-16H2,1H3,(H2,25,27,28)
InChIKeyUMNMUCMXDPFGTM-UHFFFAOYSA-N
XLogP17.21
TPSA431.69 Ų
H-Bond Donors6
H-Bond Acceptors35
Rotatable Bonds39
Heavy Atoms159
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002167.86
LogP ≤ 517.21
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1035

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one?
The IUPAC name of 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one (CID 161133803) is 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one.
What is the SMILES notation for 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one?
The canonical SMILES for 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one is CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCCC3)c1)CCC(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CNCC3CC3)c1)CCC(=O)C2.Nc1nc(OC2CCCC2)nc2c1CC(=O)CCN2Cc1cccc(CN2CCCC2)c1.Nc1nc(OCC2CCC2)nc2c1CC(=O)CCN2Cc1cccc(CN2CCCC2)c1.Nc1nc(OCCC2CC2)nc2c1CC(=O)CCN2Cc1cccc(CN2CCCC2)c1.
What is the InChIKey of 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one?
The InChIKey is UMNMUCMXDPFGTM-UHFFFAOYSA-N. The full InChI is InChI=1S/3C25H33N5O2.C25H35N5O2.C24H33N5O2/c26-23-22-14-21(31)9-12-30(24(22)28-25(27-23)32-17-18-5-3-6-18)16-20-8-4-7-19(13-20)15-29-10-1-2-11-29;26-23-22-15-20(31)10-13-30(24(22)28-25(27-23)32-21-8-1-2-9-21)17-19-7-5-6-18(14-19)16-29-11-3-4-12-29;26-23-22-15-21(31)8-12-30(24(22)28-25(27-23)32-13-9-18-6-7-18)17-20-5-3-4-19(14-20)16-29-10-1-2-11-29;1-2-3-14-32-25-27-23(26)22-16-21(31)10-13-30(24(22)28-25)18-20-9-7-8-19(15-20)17-29-11-5-4-6-12-29;1-2-3-11-31-24-27-22(25)21-13-20(30)9-10-29(23(21)28-24)16-19-6-4-5-18(12-19)15-26-14-17-7-8-17/h4,7-8,13,18H,1-3,5-6,9-12,14-17H2,(H2,26,27,28);5-7,14,21H,1-4,8-13,15-17H2,(H2,26,27,28);3-5,14,18H,1-2,6-13,15-17H2,(H2,26,27,28);7-9,15H,2-6,10-14,16-18H2,1H3,(H2,26,27,28);4-6,12,17,26H,2-3,7-11,13-16H2,1H3,(H2,25,27,28).
What are the key properties of 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one?
4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one has a molecular weight of 2167.86 g/mol, XLogP of 17.21, 39 rotatable bonds, 6 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 4-amino-2-butoxy-9-[[3-[(cyclopropylmethylamino)methyl]phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(piperidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(cyclobutylmethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-cyclopentyloxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-(2-cyclopropylethoxy)-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one is sourced from PubChem (CID 161133803), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).